Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Infectious & Toxicology
Filter     Order     Display # 
Date Item Title
15 Nov 2007 New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis
15 Nov 2007 Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
15 Nov 2007 Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
12 Nov 2007 Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra® (lopinavir/ritonavir) Tablet for Pediatric HIV Patients
09 Nov 2007 Promising clinical results from new HIV vaccine
07 Nov 2007 Epiphany Biosciences reports initiation and enrollment in Valomaciclovir study for shingles
07 Nov 2007 Sanofi Pasteur initiates phase II trial of cell
06 Nov 2007 GlobeImmune Announces Presentation of Results from a Randomized Phase 1b Study of the GI-5005 Tarmogen in Patients with Chronic Hepatitis C Infection
05 Nov 2007 Positive Results From Peregrine Pharmaceuticals' Bavituximab Phase l HCV Trial Presented at AASLD Meeting
05 Nov 2007 Human genome sciences presents results of Phase 2 trial of albuferon(R) in chronic hepatitis c patients who failed to respond to previous therapy
03 Nov 2007 Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C
03 Nov 2007 Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C
03 Nov 2007 Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels
03 Nov 2007 IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients
02 Nov 2007 Potent hepatitis C virus inhibitors show efficacy and potential for once daily dosing in preclinical studies
02 Nov 2007 Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
30 Oct 2007 Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
26 Oct 2007 Flamel Technologies Announces Positive Top Line Results of a Clinical Trial of IFN-alpha-XL versus PegIntron(TM) in Patients with Chronic Hepatitis C Virus Infection
26 Oct 2007 Panacos Announces Greater than 1 Log10 Mean Reduction in 300 mg Bevirimat Cohort
25 Oct 2007 Inhibitex Initiates Phase I Trial of FV-100 for the Treatment of Shingles
24 Oct 2007 ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
23 Oct 2007 Theravance Receives FDA Approvable Letter for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
20 Oct 2007 Barrier Therapeutics Announces Promising Results From On-Going Phase 2a Study of Pramiconazole in Onychomycosis
20 Oct 2007 European licence for Roche HIV drug Viracept re-established by European Commission
19 Oct 2007 Sanofi Pasteur receives FDA approval of meningococcal vaccine for children
19 Oct 2007 European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
18 Oct 2007 Lilly and MacroGenics Announce Licensing and Collaboration Agreement
18 Oct 2007 Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response
18 Oct 2007 Omiganan Phase II Rosacea Study Demonstrates Promising Results
17 Oct 2007 Interim Safety Data Favorable for Vical's Phase 2 Trial of DNA Vaccine Against CMV
16 Oct 2007 FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
16 Oct 2007 Medimmune and Crucell announce collaboration to develop new antibodies for the treatment and prevention of hospital-acquired bacterial infection
13 Oct 2007 OctoPlus announces positive Phase IIa efficacy and tolerability results for Locteron in hepatitis C
12 Oct 2007 Gilead Submits Marketing Applications in the United States and European Union for Viread(R) (Tenofovir Disoproxil Fumarate) for the Treatment of Chronic Hepatitis B
11 Oct 2007 Emergent BioSolutions' Typhoid Vaccine Candidate Achieves Endpoints in Phase II Clinical Study
09 Oct 2007 Basilea Announces Positive Top-line Data from Phase III Study of Ceftobiprole in Hospital-Acquired Pneumonia
09 Oct 2007 New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
09 Oct 2007 GlaxoSmithKline and Anacor Pharmaceuticals form alliance to develop systemic antivirals and antibiotics based on boron chemistry
06 Oct 2007 Interim Results from a New Trial of CANCIDAS(R) (caspofungin acetate) in Pediatric Patients with Documented Fungal Infections
04 Oct 2007 Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
04 Oct 2007 Roche and Trimeris Provide Update on Development of Alternative Administration Options for Delivery of FUZEON(R)
04 Oct 2007 MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
03 Oct 2007 Crucell presents Phase I results rabies antibody cocktail showing safety and ability to protect
02 Oct 2007 Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
02 Oct 2007 Transgene Extends Therapeutic Vaccine Candidate TG4040 Development Program Against Chronic Hepatitis C
02 Oct 2007 U.S. Food & Drug Administration approves CSL influenza virus vaccine, for marketing in the U.S.
28 Sep 2007 Crucell discovers human monoclonal antibodies for the prevention and treatment of the avian flu virus
27 Sep 2007 InterMune Announces Start of Phase 1b Trial of ITMN-191
27 Sep 2007 Cytheris Expands Interleukin-7 Clinical Development Program With International Phase I/IIa Trial In HIV
26 Sep 2007 Orexigen(TM) Announces Positive Clinical Results of Its Proprietary Naltrexone Sustained Release Formulation for Use in Contrave(TM)
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 401 - 450 of 1267

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics